Moore JP - Search Results

1

SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.

Ringe RP, Colin P, Torres JL, Yasmeen A, Lee WH, Cupo A, Ward AB, Klasse PJ, Moore JP. Ringe RP, et al. Among authors: moore jp. J Virol. 2019 Dec 12;94(1):e01521-19. doi: 10.1128/JVI.01521-19. Print 2019 Dec 12. J Virol. 2019. PMID: 31619555 Free PMC article.

2

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.

Moore JP, Sattentau QJ, Klasse PJ, Burkly LC. Moore JP, et al. J Virol. 1992 Aug;66(8):4784-93. doi: 10.1128/JVI.66.8.4784-4793.1992. J Virol. 1992. PMID: 1378510 Free PMC article.

3

Kinetics of the HIV-CD4 interactions and virus-cell fusion.

Klasse PJ, Moore JP. Klasse PJ, et al. Among authors: moore jp. AIDS. 1992 Mar;6(3):325-7. doi: 10.1097/00002030-199203000-00011. AIDS. 1992. PMID: 1567578 No abstract available.

4

Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation.

Moore JP, Klasse PJ. Moore JP, et al. AIDS Res Hum Retroviruses. 1992 Apr;8(4):443-50. doi: 10.1089/aid.1992.8.443. AIDS Res Hum Retroviruses. 1992. PMID: 1599754

5

Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.

Cordell J, Moore JP, Dean CJ, Klasse PJ, Weiss RA, McKeating JA. Cordell J, et al. Among authors: moore jp. Virology. 1991 Nov;185(1):72-9. doi: 10.1016/0042-6822(91)90755-z. Virology. 1991. PMID: 1718090

6

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.

Moore JP, Sattentau QJ, Wyatt R, Sodroski J. Moore JP, et al. J Virol. 1994 Jan;68(1):469-84. doi: 10.1128/JVI.68.1.469-484.1994. J Virol. 1994. PMID: 7504741 Free PMC article.

7

Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop.

Yoshiyama H, Mo H, Moore JP, Ho DD. Yoshiyama H, et al. Among authors: moore jp. J Virol. 1994 Feb;68(2):974-8. doi: 10.1128/JVI.68.2.974-978.1994. J Virol. 1994. PMID: 7507188 Free PMC article.

8

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

Roben P, Moore JP, Thali M, Sodroski J, Barbas CF 3rd, Burton DR. Roben P, et al. Among authors: moore jp. J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994. J Virol. 1994. PMID: 7518527 Free PMC article.

9

Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.

Kang CY, Hariharan K, Nara PL, Sodroski J, Moore JP. Kang CY, et al. Among authors: moore jp. J Virol. 1994 Sep;68(9):5854-62. doi: 10.1128/JVI.68.9.5854-5862.1994. J Virol. 1994. PMID: 7520095 Free PMC article.

10

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.

Gorny MK, Moore JP, Conley AJ, Karwowska S, Sodroski J, Williams C, Burda S, Boots LJ, Zolla-Pazner S. Gorny MK, et al. Among authors: moore jp. J Virol. 1994 Dec;68(12):8312-20. doi: 10.1128/JVI.68.12.8312-8320.1994. J Virol. 1994. PMID: 7525987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters